![Musk's Neuralink FDA review team hit by govt workforce reductions - Reuters](https://i-invdn-com.investing.com/news/moved_small-LYNXMPEK4R0RM_L.jpg)
Please try another search
Date | Price | Open | High | Low | Change % |
---|---|---|---|---|---|
Feb 17, 2025 | 211.974 | 211.974 | 211.974 | 211.974 | 0.10% |
Feb 14, 2025 | 211.773 | 211.773 | 211.773 | 211.773 | -1.04% |
Feb 13, 2025 | 214.006 | 214.006 | 214.006 | 214.006 | -0.01% |
Feb 12, 2025 | 214.020 | 214.020 | 214.020 | 214.020 | 0.03% |
Feb 11, 2025 | 213.965 | 213.965 | 213.965 | 213.965 | -1.54% |
Feb 10, 2025 | 217.320 | 217.320 | 217.320 | 217.320 | -0.90% |
Feb 07, 2025 | 219.291 | 219.291 | 219.291 | 219.291 | -0.32% |
Feb 06, 2025 | 219.993 | 219.993 | 219.993 | 219.993 | -0.28% |
Feb 05, 2025 | 220.620 | 220.620 | 220.620 | 220.620 | 0.12% |
Feb 04, 2025 | 220.353 | 220.353 | 220.353 | 220.353 | 1.26% |
Feb 03, 2025 | 217.607 | 217.607 | 217.607 | 217.607 | -0.16% |
Jan 31, 2025 | 217.957 | 217.957 | 217.957 | 217.957 | 1.07% |
Jan 30, 2025 | 215.660 | 215.660 | 215.660 | 215.660 | 0.13% |
Jan 29, 2025 | 215.370 | 215.370 | 215.370 | 215.370 | 1.37% |
Jan 28, 2025 | 212.464 | 212.464 | 212.464 | 212.464 | 0.38% |
Jan 27, 2025 | 211.662 | 211.662 | 211.662 | 211.662 | -1.74% |
Jan 24, 2025 | 215.405 | 215.405 | 215.405 | 215.405 | -0.81% |
Jan 23, 2025 | 217.155 | 217.155 | 217.155 | 217.155 | 0.83% |
Jan 22, 2025 | 215.375 | 215.375 | 215.375 | 215.375 | 0.18% |
Jan 21, 2025 | 214.980 | 214.980 | 214.980 | 214.980 | -1.69% |
Jan 20, 2025 | 218.680 | 218.680 | 218.680 | 218.680 | 0.52% |
Highest: 220.620 | Lowest: 211.662 | Difference: 8.958 | Average: 215.982 | Change %: -2.560 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review